Series B funding round for Ashvattha Therapeutics raising $69M in April 2022
Series B funding round for Ashvattha Therapeutics raising $69M in April 2022
| Investor | Firm Type |
|---|
| Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Gokul Rajaram | |
| Angel | Cory Levy | |
| Angel | Michael Stoppelman | |
| Angel | Liu Jiang |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$126M
Top Valuation
-
Ashvattha Therapeutics raised $69M in a Series B round.
The round was announced on 04/01/22.
The round was led by Huadong Medicine Company Limited.